Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trial

Journal:
Nature Medicine
Published:
Affiliations:
22
Authors:
19
Institutions Authors Share
Lilly, United States of America (USA)
3.000000
0.16
Mayo Clinic, United States of America (USA)
1.000000
0.05
Yale University, United States of America (USA)
1.000000
0.05
University of Glasgow, United Kingdom (UK)
1.000000
0.05
Brigham and Women's Hospital (BWH), United States of America (USA)
1.000000
0.05
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)
1.000000
0.05
Hadassah Medical Center, HUJI, Israel
1.000000
0.05
Hospital das Clínicas da FMUSP, Brazil
1.000000
0.05
University of São Paulo (USP), Brazil
1.000000
0.05
Centro de Investigaciones Clínicas del Litoral (CICLI), Argentina
1.000000
0.05
Saiseikai Futsukaichi Hospital, Japan
1.000000
0.05
Semmelweis University (SE), Hungary
1.000000
0.05
Dokuz Eylül University, Turkey
1.000000
0.05
Manchester Academic Health Science Centre (MAHSC), United Kingdom (UK)
0.500000
0.03
Manchester University NHS Foundation Trust (MFT), United Kingdom (UK)
0.500000
0.03
Hospital Clínico Universitario de Valencia, Spain
0.500000
0.03
Biomedical Research Institute (INCLIVA), Spain
0.500000
0.03
St. Michael's Hospital, Canada
0.500000
0.03
University of Toronto (U of T), Canada
0.500000
0.03
General University Hospital in Prague, Czech Republic
0.333333
0.02
Charles University (CU), Czech Republic
0.333333
0.02
Wroclaw Medical University, Poland
0.333333
0.02